Export 00
Xultophy 100/3.6 Injection, Solution
Product Images NDC 0169-2911
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 30 technical images submitted to the FDA as part of the official labeling for Xultophy 100/3.6 (NDC 0169-2911). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Novo Nordisk, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1: Structural Formula Of Insulin Degludec (Image 01)
Figure 2: Structural Formula Of Liraglutide (Image 02)
Figure 3: Graph For Study A (Image 03)
Figure A Picture Of The Pen And Needle Components (Image 04)
Figure L 200 Units Left (Image 05)
Image Of The Carton 5 X 3ml (Image 06)
Priming Symbol (Image 07)
XULTOPHY 100/3.6 pen is a medication delivery device designed for subcutaneous injections. It appears to have a removable pen cap.*
Qr Code For Additional Info (Image 08)
For additional information about Xultophy 10036, visit www.xultophy10036.com.*
Cover Page (Image 09)
Xultophy® 100/3.6 is a medication with a concentration of 100units/m and 36mg/ml. A warning is given to "Read before first use."*
Figure B (Image 10)
Figure C (Image 11)
Figure D (Image 12)
Figure E (Image 13)
Figure F (Image 14)
Figure G (Image 15)
Figure H (Priming)
Figure I (Image 17)
Figure K (Turn dose selector)
Image 20
Figure M (Image 21)
Figure N (Image 22)
Figure O (Press dose button)
Figure P (Image 24)
Figure Q (Image 25)
Figure R (Image 26)
Figure S (Image 27)
Figure T (Image 28)
Image 30
Image 31
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
